Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Freeman

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Antiviral Research|November 29, 2005
Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flavivirusesEva Lee, Megan Pavy, Nicolie Young, et al.
The FEBS Journal|November 19, 2009
Activation of cathepsin D by glycosaminoglycansMarie Beckman, Craig Freeman, Christopher R Parish, et al.
IUBMB Life|January 9, 2013
Proteoglycans in the central nervous system: role in development, neural repair, and Alzheimer's diseaseHao Cui, Craig Freeman, Glenn A Jacobson, et al.
Glycobiology|July 13, 2011
Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-D-glucuronidase (heparanase)Neha S Gandhi, Craig Freeman, Christopher R Parish, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2003
Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritisVicki Levidiotis, Craig Freeman, Chris Tikellis, et al.
Nephrology (Carlton, Vic.)|May 10, 2005
Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody diseaseVicki Levidiotis, Craig Freeman, Chris Tikellis, et al.
Oncogene|April 5, 2005
A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancerJohanna A Joyce, Craig Freeman, Nicole Meyer-Morse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Evidence that the cellular ligand for the human NK cell activation receptor NKp30 is not a heparan sulfate glycosaminoglycanHilary S Warren, Allison L Jones, Craig Freeman, et al.
The Journal of Clinical Investigation|December 21, 2011
Heparan sulfate and heparanase play key roles in mouse β cell survival and autoimmune diabetesAndrew F Ziolkowski, Sarah K Popp, Craig Freeman, et al.
The Journal of Biological Chemistry|March 27, 2007
Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivoJulia I Ellyard, Ljubov Simson, Anna Bezos, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Antiviral Research|November 29, 2005
Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flavivirusesEva Lee, Megan Pavy, Nicolie Young, et al.
The FEBS Journal|November 19, 2009
Activation of cathepsin D by glycosaminoglycansMarie Beckman, Craig Freeman, Christopher R Parish, et al.
IUBMB Life|January 9, 2013
Proteoglycans in the central nervous system: role in development, neural repair, and Alzheimer's diseaseHao Cui, Craig Freeman, Glenn A Jacobson, et al.
Glycobiology|July 13, 2011
Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-D-glucuronidase (heparanase)Neha S Gandhi, Craig Freeman, Christopher R Parish, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2003
Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritisVicki Levidiotis, Craig Freeman, Chris Tikellis, et al.
Nephrology (Carlton, Vic.)|May 10, 2005
Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody diseaseVicki Levidiotis, Craig Freeman, Chris Tikellis, et al.
Oncogene|April 5, 2005
A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancerJohanna A Joyce, Craig Freeman, Nicole Meyer-Morse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Evidence that the cellular ligand for the human NK cell activation receptor NKp30 is not a heparan sulfate glycosaminoglycanHilary S Warren, Allison L Jones, Craig Freeman, et al.
The Journal of Clinical Investigation|December 21, 2011
Heparan sulfate and heparanase play key roles in mouse β cell survival and autoimmune diabetesAndrew F Ziolkowski, Sarah K Popp, Craig Freeman, et al.
The Journal of Biological Chemistry|March 27, 2007
Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivoJulia I Ellyard, Ljubov Simson, Anna Bezos, et al.
Pageof 4